Clinical Trials Logo

GERD clinical trials

View clinical trials related to GERD.

Filter by:

NCT ID: NCT05469854 Recruiting - Pharmacokinetics Clinical Trials

A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate

Start date: July 13, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase I, single-center, double blind, placebo-controlled, parallel-group, randomized study designed to evaluate the PK, cardiodynamic ECG effects, safety, and tolerability of 2 single ascending oral doses of linaprazan glurate. The study will explore the PK properties of linaprazan glurate and linaprazan as well as the cardiodynamic ECG effects, safety, and tolerability after the administration of single doses (300 mg, 600 mg, 200 mg and a final dose level of maximum 400 mg) of linaprazan glurate, using 25 mg base formulation (300 mg and 600 mg doses) and 25 mg and 100 mg HCl formulation (200 mg and final dose level of maximum 400 mg) oral tablets.

NCT ID: NCT05282914 Completed - GERD Clinical Trials

A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

Start date: February 3, 2021
Phase: Phase 1
Study type: Interventional

A Study to compare pharmacokinetics, pharmacodynamics and safety of UI058 and UIC202004 in healthy subjects

NCT ID: NCT05210049 Recruiting - Obesity Clinical Trials

Non-endoscopic Esophageal Sampling to Detect Barrett's Esophagus and Esophageal Cancer in Veterans

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This study seeks to incorporate non-endoscopic detection method (Esocheck/Esoguard) in primary care practice and test whether this screening modality increases the positive predictive value of upper endoscopy and increases the detection of Barrett's esophagus and esophageal cancer.

NCT ID: NCT05192538 Recruiting - GERD Clinical Trials

A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux

Start date: February 10, 2022
Phase: N/A
Study type: Interventional

The purpose of this study was to evaluate the safety and efficacy of endoscopic endoloop pre-test for gastroesophageal reflux before anti-reflux surgery or endoscopic treatment. In the study, the investigators used the novel pre-test to narrow the gastric cardia to control symptoms temporarily to decide whether to undergo irreversible surgery or endoscopic treatment.Thirty patients were enrolled and underwent endoscopic endoloop pre-test treatment. The Primary outcome in this study was measured by the percent reduction in post-procedure GERD symptoms as evidenced by analysis of the GERD-HRQL (Health Related Quality of Life) questionnaire. The secondary outcomes included improvement in esophageal 24-hr pH monitoring, improvement in quality of life questionnaires and safety. Patient follow-up assessments were completed at 7 and 14 days post treatment.

NCT ID: NCT05178446 Completed - Morbid Obesity Clinical Trials

GERD After Sleeve Gastrectomy

Start date: January 1, 2021
Phase:
Study type: Observational

The main adverse effect is gastroesophageal reflux disease (GERD), with concern on the development of Barrett's esophagus and esophageal adenocarcinoma in the long term. However, the relationship between SG and GERD is complex. The aim of this study is to systematically evaluate all published data existing in the literature to evaluate the effect of sleeve gastrectomy on GERD, esophagitis, BE in order to clarify the long-term clinical sequelae of this procedure. This systematic review was conducted in accordance with the guidelines for Preferred Reporting Items for Systematic Review and Meta-analyzes (PRISMA). Published studies that contained outcome data for primary sleeve gastrectomy associated with the primary and secondary outcomes listed below were included.

NCT ID: NCT05131932 Not yet recruiting - Cough Clinical Trials

Ablation of Esophageal Inlet Patches in Patients Referred for Bravo pH-Testing

Start date: December 2021
Phase: N/A
Study type: Interventional

Patients with suspected extra-esophageal manifestations of gastro-esophageal reflux disease (GERD), such as cough, hoarseness, and globus, are often referred for pH testing. However, many of these symptoms may actually be due to an esophageal inlet patch. We aim to evaluate patients referred for pH testing to see if they have an inlet patch, to perform ablation of the inlet patch if detected, and then compare the outcomes of patients with an inlet patch who underwent ablation versus those without an inlet patch.

NCT ID: NCT05108038 Recruiting - GERD Clinical Trials

A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects

Start date: October 7, 2021
Phase: Phase 1
Study type: Interventional

to evaluate the pharmacokinetics, pharmacodynamics and safety after single/multiple administration of CKD-382, D860 and D027 in healthy subjects

NCT ID: NCT05089929 Completed - GERD Clinical Trials

Endoscopic Esophageal Topography (Endoflip 2.0) Versus High-resolution Manometry (HRM)

Start date: March 19, 2020
Phase:
Study type: Observational

The purpose of the study is to investigate the use of FLIP topography in patients undergoing evaluation for gastroesophageal reflux disease (GERD). This device allows the clinician to measure muscle activity in the esophagus during a routine upper endoscopy. The FLIP topography will be used to help detect movement disorders in the esophagus, and to examine differences in patient satisfaction between FLIP topography and the standard of care procedure, high resolution manometry (HRM).

NCT ID: NCT05080634 Recruiting - GERD Clinical Trials

Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy

Start date: June 1, 2021
Phase:
Study type: Observational [Patient Registry]

Achalasia is an uncommon disorder that results from the degeneration of ganglion cells of the myenteric plexus in the lower esophageal wall. Peroral endoscopic myotomy (POEM) is a minimally invasive procedure capable of overcoming limitations of achalasia treatments. This study aimed to: 1) identify the prevalence of reflux esophagitis and asymptomatic GERD in patients who underwent POEM, and 2) evaluate patient and intraprocedural variables associated with post-POEM GERD.

NCT ID: NCT05069493 Completed - Quality of Life Clinical Trials

Long-term Follow-up After Hiatal Hernia Repair by Tension-free Mesh Closure or Simple Suturing

Start date: September 15, 2021
Phase:
Study type: Observational

10 years of follow-up after surgery for hiatal hernia by tension-free mesh closure or simple suturing.